Open Post

Greywolf Therapeutics Milton, United Kingdom Posted 15 Sept 2026Full-time

About this role

TBC We want to solve immune dysfunction. Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This approach marks a fundamental shift in how we treat people living with …

How to apply

Applications are handled by the employer. Open the original advert to apply, or create a free NextMove account to track deadlines and see similar matches.